Vivos Therapeutics Inc

+0.06 (+2.26%)
6:58:58 PM EDT: $2.65 -0.07 (-2.57%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.60M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.32 Million
Adjusted EPS-$1.19
See more estimates
10-Day MA$2.84
50-Day MA$4.32
200-Day MA$6.99
See more pivots

Vivos Therapeutics Inc Stock, NASDAQ:VVOS

7921 Southpark Plaza, Suite 210, Littleton, Colorado 80120
United States of America
Phone: +1.844.908.4867
Number of Employees: 114


Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.